SCHEMBL5222798

SCHEMBL5222798

O=S(=O)(c1ccccc1)C1CNCCN1c1nc(-c2ccccc2)c2cc(Cl)ccc2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.61
KMT2A Q03164 4/20 0.61
NPSR1 Q6W5P4 3/20 0.61
LMNA P02545 2/20 0.61
S1PR2 O95136 1/20 0.61
HIF1A Q16665 1/20 0.61
ALDH1A1 P00352 4/20 0.50
CASP1 P29466 4/20 0.50
CASP7 P55210 3/20 0.50
USP2 O75604 2/20 0.50
MAPT P10636 5/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
TP53 P04637 2/20 0.46
TSHR P16473 2/20 0.46
HPGD P15428 1/20 0.42
GAA P10253 3/20 0.40
MEN1 O00255 2/20 0.40
MAT2A P31153 1/20 0.40
MAPK1 P28482 3/20 0.39
ATM Q13315 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5786483 0.76 KDM4E (1.00) KDM4EKMT2ANPSR1LMNAS1PR2
SCHEMBL5222789 0.73 KDM4E (0.68) KDM4EKMT2ANPSR1LMNAS1PR2
SCHEMBL3796418 0.71 SLC6A2 (0.49) HTR1AHTR2AHTR7HTR6
SCHEMBL5786677 0.69 KDM4E (0.84) KDM4EKMT2ANPSR1LMNAS1PR2
SCHEMBL28440794 0.68 SLC6A2 (0.41) NPSR1HIF1AMAPTSMN1; SMN2TSHR
SCHEMBL6329724 0.67 ALDH1A1 (0.64) KDM4EKMT2ANPSR1LMNAS1PR2
SCHEMBL14586373 0.67 KDM4E (1.00) KDM4EKMT2ANPSR1LMNAS1PR2
SCHEMBL5787049 0.67 ALDH1A1 (0.64) KDM4EKMT2ANPSR1LMNAS1PR2
SCHEMBL1887877 0.67 CA12 (0.39) HTR6
Hydrochloric Acid SCHEMBL6335375 0.66 ALDH1A1 (0.62) KDM4EKMT2ANPSR1LMNAS1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009817-A1 Substituted heteroaryls INSTITUTES FOR PHARMACEUTICAL DISCOVERY, L.L.C. 2005-01-13 US claimed
EP-1618094-B1 SUBSTITUTED HETEROARYLS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INST FOR PHARM DISCOVERY INC (US) 2007-09-05 EP disclosed
US-20050009817-A1 Substituted heteroaryls INSTITUTES FOR PHARMACEUTICAL DISCOVERY, L.L.C. 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009817-A1 Substituted heteroaryls PTPRS, PTPRO, PTPRR KDM4E 1400/4885KMT2A 2730/4885NPSR1 2032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.